-
Post date
January 14, 2022
-
Posted by
Kieran Robertson
-
Posted in
clinical trial, clinical trials psilocybin 2021, Mushrooms, NBIO-01, NUMI.T, Numinus Health, numinus stock, Numinus Wellness Inc., Numinus Wellness Inc. (NUMI.T), Patent, Patent Application, patent pending, process technology, psilocybin, psychedelic-assisted psychotherapies, Psychedelics
-
Post date
August 16, 2021
-
Posted by
Piers Eaton
-
Posted in
Biotech, Eaton, Featured Content, Filament, Filament Health, filament health ipo, Filament Health Natural Psychedelic, filament health neo, Filament Health Trials, Health Science, Mushrooms, Natural Psychedelic, patents, psilocybin, Psychedelic Patents, Psychedelic Stocks, psychedelic therapy, Psychedelics, Scribes, Series
-
Post date
August 16, 2021
-
Posted by
Piers Eaton
-
Posted in
Biotech, Eaton, Featured Content, Filament, Filament Health, filament health ipo, Filament Health Natural Psychedelic, filament health neo, Filament Health Trials, Health Science, Mushrooms, Natural Psychedelic, patents, psilocybin, Psychedelic Patents, Psychedelic Stocks, psychedelic therapy, Psychedelics, Scribes, Series
-
Post date
August 9, 2021
-
Posted by
Piers Eaton
-
Posted in
Biotech, Eaton, Featured Content, Filament, Filament Health, filament health ipo, Filament Health Natural Psychedelic, filament health neo, Filament Health Trials, Health Science, Mushrooms, Natural Psychedelic, patents, psilocybin, Psychedelic Patents, Psychedelic Stocks, psychedelic therapy, Psychedelics, Scribes
-
Post date
July 13, 2021
-
Posted by
Piers Eaton
-
Posted in
baeocystin, Biotech, Eaton, Health Science, Mushrooms, Norbaeocystin, psilocybin, PSYB.V, PsyBio, PsyBio therapeutics, Psychedelics, Scribes
